Advertisement
U.S. Markets closed

  • S&P 500

    5,702.55
    -11.09 (-0.19%)
    ?

  • Dow 30

    42,063.36
    +38.17 (+0.09%)
    ?

  • Nasdaq

    17,948.32
    -65.66 (-0.36%)
    ?

  • Russell 2000

    2,227.89
    -24.82 (-1.10%)
    ?

  • Crude Oil

    71.77
    -0.18 (-0.25%)
    ?

  • Gold

    2,647.10
    +32.50 (+1.24%)
    ?

  • Silver

    31.50
    +0.07 (+0.23%)
    ?

  • EUR/USD

    1.1166
    0.0000 (-0.0000%)
    ?

  • 10-Yr Bond

    3.7280
    -0.0120 (-0.32%)
    ?

  • Vix

    16.15
    -0.18 (-1.10%)
    ?

  • GBP/USD

    1.3323
    +0.0038 (+0.2891%)
    ?

  • USD/JPY

    143.8080
    +1.1710 (+0.8210%)
    ?

  • BTC-USD

    63,055.37
    -198.68 (-0.31%)
    ?

  • CMC Crypto 200

    1,308.28
    0.00 (0.00%)
    ?

  • FTSE 100

    8,229.99
    -98.73 (-1.19%)
    ?

  • Nikkei 225

    37,723.91
    +568.58 (+1.53%)
    ?

Semler Scientific Second Quarter 2024 Earnings: EPS: US$0.002 (vs US$0.88 in 2Q 2023)

[email protected] (Simply Wall St)
1 min read
In this article:

Semler Scientific (NASDAQ:SMLR) Second Quarter 2024 Results

Key Financial Results

  • Revenue: US$14.5m (down 22% from 2Q 2023).

  • Net income: US$11.0k (down 100% from 2Q 2023).

  • Profit margin: 0.1% (down from 32% in 2Q 2023). The decrease in margin was primarily driven by lower revenue.

  • EPS: US$0.002 (down from US$0.88 in 2Q 2023).

earnings-and-revenue-history
earnings-and-revenue-history

All figures shown in the chart above are for the trailing 12 month (TTM) period

Semler Scientific shares are down 20% from a week ago.

Risk Analysis

It's necessary to consider the ever-present spectre of investment risk. We've identified 2 warning signs with Semler Scientific (at least 1 which is significant), and understanding these should be part of your investment process.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected]

Advertisement